Prot #KT-US-472-0141: Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Brexucabtagene Autoleuce

Project: Research project

Project Details

StatusActive
Effective start/end date1/22/241/22/27

Funding

  • ICON Clinical Research Limited (Prot #KT-US-472-0141 // Prot #KT-US-472-0141)
  • Kite Pharma, Inc. (Prot #KT-US-472-0141 // Prot #KT-US-472-0141)